Switzerland

Top 11 largest Swiss Companies in the Biotechnology industry by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry from Switzerland by market capitalization with links to their reference stock.

Switzerland Biotechnology Industry Analysis
Top Swiss Companies Switzerland Analysis
World Top Companies World Companies Analysis

Top Biotechnology Companies from Switzerland as of Jul. 01, 2024

1. CRISPR Therapeutics AG

Company Profile: CRISPR Therapeutics AG
Market Cap (USD): $4.51 B
Country: Switzerland
Sector: Swiss Healthcare
Industry: Swiss Biotechnology

2. BB Biotech AG

Company Profile: BB Biotech AG
Market Cap (USD): $2.40 B
Country: Switzerland
Sector: Swiss Healthcare
Industry: Swiss Biotechnology

3. VectivBio Holding AG

Company Profile: VectivBio Holding AG
Market Cap (USD): $474.9 M (Jan. 1, 2023)
Country: Switzerland
Sector: Swiss Healthcare
Industry: Swiss Biotechnology

4. Kuros Biosciences AG

Company Profile: Kuros Biosciences AG
Market Cap (USD): $468.5 M
Country: Switzerland
Sector: Swiss Healthcare
Industry: Swiss Biotechnology

5. Idorsia Ltd

Company Profile: Idorsia Ltd
Market Cap (USD): $432.2 M
Country: Switzerland
Sector: Swiss Healthcare
Industry: Swiss Biotechnology

6. AC Immune SA

Company Profile: AC Immune SA
Market Cap (USD): $355.0 M
Country: Switzerland
Sector: Swiss Healthcare
Industry: Swiss Biotechnology

7. ADC Therapeutics SA

Company Profile: ADC Therapeutics SA
Market Cap (USD): $313.7 M
Country: Switzerland
Sector: Swiss Healthcare
Industry: Swiss Biotechnology

8. Xlife Sciences AG

Company Profile: Xlife Sciences AG
Market Cap (USD): $233.3 M (Feb. 1, 2022)
Country: Switzerland
Sector: Swiss Healthcare
Industry: Swiss Biotechnology

9. Molecular Partners AG

Company Profile: Molecular Partners AG
Market Cap (USD): $224.2 M
Country: Switzerland
Sector: Swiss Healthcare
Industry: Swiss Biotechnology

10. Santhera Pharmaceuticals Holding AG

Company Profile: Santhera Pharmaceuticals Holding AG
Market Cap (USD): $104.7 M
Country: Switzerland
Sector: Swiss Healthcare
Industry: Swiss Biotechnology

11. NLS Pharmaceutics AG

Company Profile: NLS Pharmaceutics AG
Market Cap (USD): $20.0 M (Jan. 1, 2024)
Country: Switzerland
Sector: Swiss Healthcare
Industry: Swiss Biotechnology